サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375475

生体適合材料市場：材料タイプ別、最終用途別-2023-2030年の世界予測

Biocompatible Materials Market by Material Type (Biocompatible Ceramic, Biocompatible Metals, Natural Polymers), End-use (Academic & Research Institutes, Pharmaceutical) - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生体適合材料市場：材料タイプ別、最終用途別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生体適合材料市場は、2022年の118億4,000万米ドルから2030年には207億2,000万米ドルに達すると予測され、予測期間中のCAGRは7.24%です。

生体適合材料の世界市場

主な市場の統計
市場金額：基準年[2022] 118億4,000万米ドル
推定市場金額[2023] 126億3,000万米ドル
予測市場金額[2030] 207億2,000万米ドル
CAGR（%） 7.24%
生体適合材料 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは生体適合材料市場の評価に不可欠なツールです。事業戦略や製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.生体適合材料市場の市場規模および予測は？

2.生体適合材料市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.生体適合材料市場における競争戦略の窓とは？

4.生体適合材料市場の最新技術動向と規制の枠組みは？

5.生体適合材料市場における主要ベンダーの市場シェアは？

6.生体適合材料市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 医療アプリケーション向けの高度な3D生体適合材料の採用が増加。
      • ドラッグデリバリーシステム、美容インプラント、創傷被覆材に対する生体適合材料の需要の増加
    • 抑制要因
      • 生体適合材料の開発に伴う高額なコスト
    • 機会
      • 個別化医療、カスタマイズされた医療機器およびインプラントへの注目の高まり
      • 組織工学用の足場、担体、および細胞ベースの治療を提供するための再生医療の需要の増加
    • 課題
      • 生体適合材料の承認に関する厳格な規制と基準
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 生体適合材料市場材質別

  • 生体適合性セラミック
  • 生体適合性金属
  • 天然ポリマー
  • 合成ポリマー

第7章 生体適合材料市場：最終用途別

  • 学術調査機関
  • 医薬品

第8章 南北アメリカの生体適合材料市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の生体適合材料市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの生体適合材料市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 競争力のあるポートフォリオ

  • 主要企業プロファイル
    • 3 H Technology Institute, LLC
    • 3D Systems Corporation
    • Ashland Inc.
    • BASF SE
    • Baxter International, Inc.
    • Celanese Corporation
    • Covestro AG
    • DuPont de Nemours, Inc.
    • Elix Polymers SLU
    • Ensinger GmbH
    • EOS GmbH
    • Evonik Industries AG
    • Formlabs Inc.
    • Foster Corporation.
    • Henkel AG & Co. KGaA,
    • Koninklijke DSM N.V.
    • Kurt J. Lesker Company GmbH
    • Merck KGaA
    • Mitsubishi Chemical Corporation
    • Renishaw PLC
    • Sandvik AB
    • Shin-Etsu Chemical Co., Ltd.
    • Stratasys Ltd.
    • Stryker Corporation
    • Wacker Chemie AG
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOCOMPATIBLE MATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCOMPATIBLE MATERIALS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOCOMPATIBLE MATERIALS MARKET DYNAMICS
  • FIGURE 7. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2022 VS 2030 (%)
  • FIGURE 8. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
  • FIGURE 10. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOCOMPATIBLE MATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE CERAMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE METALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 11. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOCOMPATIBLE MATERIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 100. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 101. BIOCOMPATIBLE MATERIALS MARKET LICENSE & PRICING
目次
Product Code: MRR-521BAA36EA37

The Biocompatible Materials Market is projected to reach USD 20.72 billion by 2030 from USD 11.84 billion in 2022, at a CAGR of 7.24% during the forecast period.

Global Biocompatible Materials Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 11.84 billion
Estimated Year Value [2023] USD 12.63 billion
Forecast Year Value [2030] USD 20.72 billion
CAGR (%) 7.24%
Biocompatible Materials Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biocompatible Materials Market.

Based on Material Type, market is studied across Biocompatible Ceramic, Biocompatible Metals, Natural Polymers, and Synthetic Polymers. The Biocompatible Metals is projected to witness significant market share during forecast period.

Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biocompatible Materials Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biocompatible Materials Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biocompatible Materials Market, highlighting leading vendors and their innovative profiles. These include 3 H Technology Institute, LLC, 3D Systems Corporation, Ashland Inc., BASF SE, Baxter International, Inc., Celanese Corporation, Covestro AG, DuPont de Nemours, Inc., Elix Polymers SLU, Ensinger GmbH, EOS GmbH, Evonik Industries AG, Formlabs Inc., Foster Corporation., Henkel AG & Co. KGaA,, Koninklijke DSM N.V., Kurt J. Lesker Company GmbH, Merck KGaA, Mitsubishi Chemical Corporation, Renishaw PLC, Sandvik AB, Shin-Etsu Chemical Co., Ltd., Stratasys Ltd., Stryker Corporation, and Wacker Chemie AG.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biocompatible Materials Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biocompatible Materials Market?

3. What is the competitive strategic window for identifying opportunities in the Biocompatible Materials Market?

4. What are the latest technology trends and regulatory frameworks in the Biocompatible Materials Market?

5. What is the market share of the leading vendors in the Biocompatible Materials Market?

6. Which modes and strategic moves are suitable for entering the Biocompatible Materials Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biocompatible Materials Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in adoption of advanced 3D biocompatible materials for medical applications.
      • 5.1.1.2. Growing demand for biocompatible materials for drug delivery systems, cosmetic implants, and wound dressing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of biocompatible materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicines and customized medical devices and implants
      • 5.1.3.2. Increasing demand for regenerative medicines for providing scaffolds, carriers for tissue engineering, and cell-based therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards for approval of biocompatible materials
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biocompatible Materials Market, by Material Type

  • 6.1. Introduction
  • 6.2. Biocompatible Ceramic
  • 6.3. Biocompatible Metals
  • 6.4. Natural Polymers
  • 6.5. Synthetic Polymers

7. Biocompatible Materials Market, by End-use

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Pharmaceutical

8. Americas Biocompatible Materials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biocompatible Materials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biocompatible Materials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. 3 H Technology Institute, LLC
    • 12.1.2. 3D Systems Corporation
    • 12.1.3. Ashland Inc.
    • 12.1.4. BASF SE
    • 12.1.5. Baxter International, Inc.
    • 12.1.6. Celanese Corporation
    • 12.1.7. Covestro AG
    • 12.1.8. DuPont de Nemours, Inc.
    • 12.1.9. Elix Polymers SLU
    • 12.1.10. Ensinger GmbH
    • 12.1.11. EOS GmbH
    • 12.1.12. Evonik Industries AG
    • 12.1.13. Formlabs Inc.
    • 12.1.14. Foster Corporation.
    • 12.1.15. Henkel AG & Co. KGaA,
    • 12.1.16. Koninklijke DSM N.V.
    • 12.1.17. Kurt J. Lesker Company GmbH
    • 12.1.18. Merck KGaA
    • 12.1.19. Mitsubishi Chemical Corporation
    • 12.1.20. Renishaw PLC
    • 12.1.21. Sandvik AB
    • 12.1.22. Shin-Etsu Chemical Co., Ltd.
    • 12.1.23. Stratasys Ltd.
    • 12.1.24. Stryker Corporation
    • 12.1.25. Wacker Chemie AG
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing